Home / ALPMY : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ALPMY make money? Does ALPMY have pricing power? What's the Earnings Whisper? Will ALPMY profit more as the business scales? What is ALPMY's management track record? Is ALPMY's current price justified?

Astellas Pharma Inc.

$14.56 +$1.24 (+9.31%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$14.22

Day Range

$14.53$14.61

Year Range

$10.03$17.35

Market Cap

26.11B

AVG Volume

170.13K

Trailing/Forward PE

11/0.07

PEG ratio

11.36

Dividend Yield

3.48%

Next Earnings Date

2026-10-29

Primary Exchange

Other OTC

Revenue (JPY)

ALPMY Revenue (JPY) by year
Period	Revenue (JPY)
2026	2.27T
2025	1.91T
2024	1.6T
2023	1.52T
2022	1.3T
2021	1.25T
2020	1.3T
2019	1.31T
2018	1.3T
2017	1.31T

Net Income (JPY)

ALPMY Net Income (JPY) by year
Period	Net Income (JPY)
2026	309.12B
2025	50.75B
2024	12.9B
2023	98.72B
2022	124.08B
2021	120.59B
2020	195.41B
2019	222.26B
2018	164.68B
2017	218.7B

Operating Income (JPY)

ALPMY Operating Income (JPY) by year
Period	Operating Income (JPY)
2026	445.01B
2025	41.04B
2024	178.07B
2023	285.43B
2022	220.02B
2021	206.62B
2020	267.48B
2019	282.42B
2018	271.82B
2017	273.81B

EBITDA (JPY)

ALPMY EBITDA (JPY) by year
Period	EBITDA (JPY)
2026	445.01B
2025	248.05B
2024	190.68B
2023	246.88B
2022	241.52B
2021	285.16B
2020	314.75B
2019	313.73B
2018	279.93B
2017	334.79B

Cash Flows (JPY)

ALPMY Cash Flows (JPY) by year
Period	Cash Flows (JPY)
2026	516.06B
2025	157.51B
2024	98.83B
2023	243.78B
2022	181.71B
2021	265.83B
2020	180.73B
2019	233.44B
2018	287.54B
2017	206.6B

EPS (JPY)

ALPMY EPS (JPY) by year
Period	EPS (JPY)
2026	172.56
2025	27.53
2024	7.11
2023	53.93
2022	66.89
2021	64.88
2020	103.78
2019	114.87
2018	80.93
2017	103.44

Expenses (JPY)

ALPMY Expenses (JPY) by year
Period	Expenses (JPY)
2026	970.64B
2025	1.21T
2024	1.12T
2023	994.94B
2022	871.3B
2021	770.3B
2020	764.76B
2019	724.15B
2018	724.21B
2017	707.89B

Cash & Debt (JPY)

ALPMY Cash & Debt (JPY) by year
Period	Cash & Debt (JPY)
2026	282.83B
2025	218.31B
2024	364.47B
2023	376.84B
2022	315.99B
2021	326.13B
2020	327.85B
2019	313.68B
2018	345.25B
2017	354.48B

Debt ratios

ALPMY Debt ratios by year
Period	Debt ratios
2026	0.35
2025	0.66
2024	0.67
2023	-0.16
2022	-0.09
2021	-0.04
2020	0.06
2019	-0.25

Margins

ALPMY Margins by year
Period	Margins
2026	74.55%
2025	81.74%
2024	75.6%
2023	78.48%
2022	78.3%
2021	79.79%
2020	78.73%
2019	77.64%
2018	77.37%
2017	75.57%

Return on Capital

ALPMY Return on Capital by year
Period	Return on Capital
2026	16.81%
2025	3.35%
2024	0.81%
2023	6.55%
2022	8.5%
2021	8.7%
2020	15.16%
2019	17.66%
2018	12.98%
2017	17.2%

Shares Outstanding

ALPMY Shares Outstanding by year
Period	Shares Outstanding
2026	1.79B
2025	1.82B
2024	1.79B
2023	1.81B
2022	1.84B
2021	1.86B
2020	1.86B
2019	1.9B
2018	2B
2017	2.08B

Dividends (JPY)

ALPMY Dividends (JPY) by year
Period	Dividends (JPY)
2026	0.46
2025	0.51
2024	0.47
2023	0.45
2022	0.41
2021	0.41
2020	0.39
2019	0.36
2018	0.33
2017	0.31

Book Value Per Share (JPY)

ALPMY Book Value Per Share (JPY) by year
Period	Book Value Per Share (JPY)
2026	1026.64
2025	832.33
2024	890.12
2023	833.34
2022	793.63
2021	746.58
2020	692.64
2019	661.23
2018	635.04
2017	610.85

Total Assets (JPY)

ALPMY Total Assets (JPY) by year
Period	Total Assets (JPY)
2026	3.58T
2025	3.34T
2024	3.57T
2023	2.46T
2022	2.33T
2021	2.27T
2020	2.32T
2019	1.9T
2018	1.86T
2017	1.82T

PE Ratio

ALPMY PE Ratio by year
Period	PE Ratio
Sep 26	12.95
Sep 26	13.63
Aug 26	13.66
Aug 26	13.86
Aug 26	13.59
Aug 26	13.52
Jul 26	12.53
Jul 26	12.54
Jul 26	12.49
Jul 26	12.39
Jul 26	12.41
Jun 26	11.85
Jun 26	11.95
Jun 26	11.81
Jun 26	11.65
May 26	12.4
May 26	12.43
May 26	12.81
May 26	12.62
May 26	12.05
Apr 26	13.5
Apr 26	14.22
Apr 26	14.41
Apr 26	14.45
Mar 26	36.58
Mar 26	33.11
Mar 26	33.21
Mar 26	33.41
Feb 26	36.54
Feb 26	35.04
Feb 26	35.71
Feb 26	35.1
Jan 26	30.43
Jan 26	31.66
Jan 26	31.57
Jan 26	31.97
Jan 26	29.63
Dec 25	46.13
Dec 25	46.69
Dec 25	44.86
Dec 25	44.04
Nov 25	43.13
Nov 25	43.22
Nov 25	41.7
Nov 25	38.6
Oct 25	35.39
Oct 25	35.63
Oct 25	35.37
Oct 25	34.8
Oct 25	35.77
Sep 25	59.17
Sep 25	59.58
Sep 25	60.57
Sep 25	60.6
Aug 25	57.68
Aug 25	60.46
Aug 25	59.51
Aug 25	58.05
Aug 25	55.81
Jul 25	52.69
Jul 25	51.66
Jul 25	50.22
Jul 25	49.84
Mar 25	48.85
Mar 25	48.97
Mar 25	48.27
Mar 25	47.93
Feb 25	48.02
Feb 25	47.68
Feb 25	48.86
Feb 25	46.73
Jan 25	49.32
Jan 25	49.16
Jan 25	48.95
Jan 25	49.04
Jan 25	49.89
Dec 24	157.67
Dec 24	158.18
Dec 24	159.96
Dec 24	163.01
Nov 24	160.57
Nov 24	161.3
Nov 24	170.58
Nov 24	176.09
Nov 24	184.24
Oct 24	178.38
Oct 24	181.14
Oct 24	180.38
Oct 24	178.95
Sep 24	234.44
Sep 24	241.63
Sep 24	234.9
Sep 24	245.04
Aug 24	251.95
Aug 24	252.26
Aug 24	236.14
Aug 24	226.1
Aug 24	238.51
Jul 24	234.94
Jul 24	226.1

Free Cash Flow Yield

ALPMY Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	12.89%
Sep 26	12.25%
Aug 26	12.22%
Aug 26	12.04%
Aug 26	12.29%
Aug 26	12.35%
Jul 26	13.33%
Jul 26	13.31%
Jul 26	13.36%
Jul 26	13.47%
Jul 26	13.45%
Jun 26	10.78%
Jun 26	10.69%
Jun 26	10.81%
Jun 26	10.96%
May 26	10.3%
May 26	10.28%
May 26	9.97%
May 26	10.12%
May 26	10.6%
Apr 26	9.46%
Apr 26	8.98%
Apr 26	8.86%
Apr 26	8.84%
Mar 26	8.12%
Mar 26	8.97%
Mar 26	8.94%
Mar 26	8.89%
Feb 26	8.13%
Feb 26	8.48%
Feb 26	8.32%
Feb 26	8.46%
Jan 26	9.76%
Jan 26	9.38%
Jan 26	9.41%
Jan 26	9.29%
Jan 26	10.02%
Dec 25	5.34%
Dec 25	5.28%
Dec 25	5.49%
Dec 25	5.59%
Nov 25	5.71%
Nov 25	5.7%
Nov 25	5.91%
Nov 25	6.38%
Oct 25	6.96%
Oct 25	6.91%
Oct 25	6.96%
Oct 25	7.08%
Oct 25	6.89%
Sep 25	5.25%
Sep 25	5.21%
Sep 25	5.12%
Sep 25	5.12%
Aug 25	5.38%
Aug 25	5.13%
Aug 25	5.22%
Aug 25	5.35%
Aug 25	5.56%
Jul 25	5.89%
Jul 25	6.01%
Jul 25	6.18%
Jul 25	6.23%
Jun 25	4.83%
Jun 25	5%
Jun 25	4.86%
Jun 25	4.83%
May 25	4.77%
May 25	4.88%
May 25	4.94%
May 25	4.85%
May 25	4.61%
Apr 25	4.66%
Apr 25	5.07%
Apr 25	5.3%
Apr 25	5%
Mar 25	5.24%
Mar 25	5.23%
Mar 25	5.31%
Mar 25	5.34%
Feb 25	5.33%
Feb 25	5.37%
Feb 25	5.24%
Feb 25	5.48%
Jan 25	5.19%
Jan 25	5.21%
Jan 25	5.23%
Jan 25	5.22%
Jan 25	5.14%
Dec 24	3.66%
Dec 24	3.64%
Dec 24	3.6%
Dec 24	3.54%
Nov 24	3.59%
Nov 24	3.57%
Nov 24	3.38%
Nov 24	3.27%
Nov 24	3.13%
Oct 24	3.23%
Oct 24	3.18%

Price to Sales

ALPMY Price to Sales by year
Period	Price to Sales
Sep 26	1.76
Sep 26	1.86
Aug 26	1.86
Aug 26	1.89
Aug 26	1.85
Aug 26	1.84
Jul 26	1.71
Jul 26	1.71
Jul 26	1.7
Jul 26	1.69
Jul 26	1.69
Jun 26	1.86
Jun 26	1.87
Jun 26	1.85
Jun 26	1.83
May 26	1.94
May 26	1.95
May 26	2.01
May 26	1.98
May 26	1.89
Apr 26	2.12
Apr 26	2.23
Apr 26	2.26
Apr 26	2.26
Mar 26	2.29
Mar 26	2.07
Mar 26	2.08
Mar 26	2.09
Feb 26	2.29
Feb 26	2.19
Feb 26	2.24
Feb 26	2.2
Jan 26	1.91
Jan 26	1.98
Jan 26	1.98
Jan 26	2
Jan 26	1.86
Dec 25	1.93
Dec 25	1.96
Dec 25	1.88
Dec 25	1.85
Nov 25	1.81
Nov 25	1.81
Nov 25	1.75
Nov 25	1.62
Oct 25	1.48
Oct 25	1.49
Oct 25	1.48
Oct 25	1.46
Oct 25	1.5
Sep 25	1.57
Sep 25	1.58
Sep 25	1.61
Sep 25	1.61
Aug 25	1.53
Aug 25	1.6
Aug 25	1.58
Aug 25	1.54
Aug 25	1.48
Jul 25	1.4
Jul 25	1.37
Jul 25	1.33
Jul 25	1.32
Jun 25	1.34
Jun 25	1.29
Jun 25	1.33
Jun 25	1.34
May 25	1.36
May 25	1.32
May 25	1.31
May 25	1.33
May 25	1.4
Apr 25	1.39
Apr 25	1.28
Apr 25	1.22
Apr 25	1.29
Mar 25	1.51
Mar 25	1.51
Mar 25	1.49
Mar 25	1.48
Feb 25	1.48
Feb 25	1.47
Feb 25	1.51
Feb 25	1.44
Jan 25	1.52
Jan 25	1.52
Jan 25	1.51
Jan 25	1.51
Jan 25	1.54
Dec 24	1.61
Dec 24	1.62
Dec 24	1.63
Dec 24	1.66
Nov 24	1.64
Nov 24	1.65
Nov 24	1.74
Nov 24	1.8
Nov 24	1.88
Oct 24	1.82
Oct 24	1.85

EV/EBITDA

ALPMY EV/EBITDA by year
Period	EV/EBITDA
Sep 26	9.88
Sep 26	10.35
Aug 26	10.37
Aug 26	10.51
Aug 26	10.32
Aug 26	10.27
Jul 26	9.58
Jul 26	9.59
Jul 26	9.56
Jul 26	9.49
Jul 26	9.51
Jun 26	7.23
Jun 26	7.29
Jun 26	7.21
Jun 26	7.12
May 26	7.53
May 26	7.55
May 26	7.75
May 26	7.65
May 26	7.34
Apr 26	8.13
Apr 26	8.52
Apr 26	8.62
Apr 26	8.65
Mar 26	9.47
Mar 26	8.65
Mar 26	8.67
Mar 26	8.72
Feb 26	9.46
Feb 26	9.1
Feb 26	9.26
Feb 26	9.12
Jan 26	8.02
Jan 26	8.31
Jan 26	8.29
Jan 26	8.38
Jan 26	7.83
Dec 25	9.48
Dec 25	9.58
Dec 25	9.26
Dec 25	9.12
Nov 25	8.96
Nov 25	8.98
Nov 25	8.71
Nov 25	8.17
Oct 25	7.61
Oct 25	7.66
Oct 25	7.61
Oct 25	7.51
Oct 25	7.68
Sep 25	14.58
Sep 25	14.66
Sep 25	14.86
Sep 25	14.87
Aug 25	14.27
Aug 25	14.84
Aug 25	14.65
Aug 25	14.35
Aug 25	13.89
Jul 25	13.25
Jul 25	13.04
Jul 25	12.75
Jul 25	12.67
Jun 25	21.51
Jun 25	20.93
Jun 25	21.4
Jun 25	21.52
May 25	21.74
May 25	21.32
May 25	21.14
May 25	21.46
May 25	22.31
Apr 25	22.1
Apr 25	20.73
Apr 25	20.04
Apr 25	20.95
Mar 25	35.77
Mar 25	35.84
Mar 25	35.42
Mar 25	35.22
Feb 25	35.27
Feb 25	35.07
Feb 25	35.77
Feb 25	34.5
Jan 25	36.05
Jan 25	35.95
Jan 25	35.83
Jan 25	35.88
Jan 25	36.39
Dec 24	68.58
Dec 24	68.75
Dec 24	69.37
Dec 24	70.43
Nov 24	69.59
Nov 24	69.84
Nov 24	73.06
Nov 24	74.98
Nov 24	77.81
Oct 24	75.78
Oct 24	76.73

Price/Operating Cashflow

ALPMY Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	7.7
Sep 26	8.1
Aug 26	8.12
Aug 26	8.24
Aug 26	8.08
Aug 26	8.04
Jul 26	7.45
Jul 26	7.45
Jul 26	7.43
Jul 26	7.37
Jul 26	7.38
Jun 26	9.34
Jun 26	9.42
Jun 26	9.31
Jun 26	9.18
May 26	9.78
May 26	9.8
May 26	10.1
May 26	9.95
May 26	9.5
Apr 26	10.64
Apr 26	11.21
Apr 26	11.36
Apr 26	11.39
Mar 26	13.03
Mar 26	11.79
Mar 26	11.83
Mar 26	11.9
Feb 26	13.01
Feb 26	12.48
Feb 26	12.72
Feb 26	12.5
Jan 26	10.84
Jan 26	11.27
Jan 26	11.24
Jan 26	11.38
Jan 26	10.55
Dec 25	20.64
Dec 25	20.89
Dec 25	20.07
Dec 25	19.7
Nov 25	19.3
Nov 25	19.34
Nov 25	18.66
Nov 25	17.27
Oct 25	15.83
Oct 25	15.94
Oct 25	15.83
Oct 25	15.57
Oct 25	16
Sep 25	15.44
Sep 25	15.54
Sep 25	15.8
Sep 25	15.81
Aug 25	15.05
Aug 25	15.77
Aug 25	15.53
Aug 25	15.14
Aug 25	14.56
Jul 25	13.75
Jul 25	13.48
Jul 25	13.1
Jul 25	13
Jun 25	15.12
Jun 25	14.59
Jun 25	15.01
Jun 25	15.12
May 25	15.32
May 25	14.95
May 25	14.78
May 25	15.07
May 25	15.84
Apr 25	15.65
Apr 25	14.41
Apr 25	13.78
Apr 25	14.61
Mar 25	13.21
Mar 25	13.24
Mar 25	13.05
Mar 25	12.96
Feb 25	12.98
Feb 25	12.89
Feb 25	13.21
Feb 25	12.64
Jan 25	13.34
Jan 25	13.29
Jan 25	13.24
Jan 25	13.26
Jan 25	13.49
Dec 24	15.42
Dec 24	15.47
Dec 24	15.64
Dec 24	15.94
Nov 24	15.7
Nov 24	15.77
Nov 24	16.68
Nov 24	17.22
Nov 24	18.02
Oct 24	17.44
Oct 24	17.71

Price to Book

ALPMY Price to Book by year
Period	Price to Book
Sep 26	2.18
Sep 26	2.29
Aug 26	2.3
Aug 26	2.33
Aug 26	2.28
Aug 26	2.27
Jul 26	2.11
Jul 26	2.11
Jul 26	2.1
Jul 26	2.08
Jul 26	2.09
Jun 26	2.19
Jun 26	2.21
Jun 26	2.18
Jun 26	2.15
May 26	2.29
May 26	2.29
May 26	2.36
May 26	2.33
May 26	2.22
Apr 26	2.49
Apr 26	2.63
Apr 26	2.66
Apr 26	2.67
Mar 26	2.82
Mar 26	2.55
Mar 26	2.56
Mar 26	2.58
Feb 26	2.82
Feb 26	2.7
Feb 26	2.75
Feb 26	2.71
Jan 26	2.35
Jan 26	2.44
Jan 26	2.43
Jan 26	2.46
Jan 26	2.28
Dec 25	2.54
Dec 25	2.57
Dec 25	2.47
Dec 25	2.42
Nov 25	2.37
Nov 25	2.38
Nov 25	2.3
Nov 25	2.12
Oct 25	1.95
Oct 25	1.96
Oct 25	1.95
Oct 25	1.92
Oct 25	1.97
Sep 25	1.98
Sep 25	2
Sep 25	2.03
Sep 25	2.03
Aug 25	1.93
Aug 25	2.03
Aug 25	2
Aug 25	1.95
Aug 25	1.87
Jul 25	1.77
Jul 25	1.73
Jul 25	1.68
Jul 25	1.67
Jun 25	1.67
Jun 25	1.62
Jun 25	1.66
Jun 25	1.67
May 25	1.7
May 25	1.65
May 25	1.64
May 25	1.67
May 25	1.75
Apr 25	1.73
Apr 25	1.6
Apr 25	1.53
Apr 25	1.62
Mar 25	1.75
Mar 25	1.75
Mar 25	1.73
Mar 25	1.72
Feb 25	1.72
Feb 25	1.71
Feb 25	1.75
Feb 25	1.67
Jan 25	1.76
Jan 25	1.76
Jan 25	1.75
Jan 25	1.75
Jan 25	1.79
Dec 24	1.63
Dec 24	1.64
Dec 24	1.66
Dec 24	1.69
Nov 24	1.66
Nov 24	1.67
Nov 24	1.77
Nov 24	1.83
Nov 24	1.91
Oct 24	1.85
Oct 24	1.88

No video analysis for this stock yet. Request one from our team.

News: ALPMY

zacks.com · 1 Sep 2026

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.

defenseworld.net · 31 Aug 2026

Kyowa Kirin (OTCMKTS:KYKOF) and Astellas Pharma (OTCMKTS:ALPMY) Head to Head Analysis

Astellas Pharma (OTCMKTS:ALPMY - Get Free Report) and Kyowa Kirin (OTCMKTS:KYKOF - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, profitability, risk and valuation. Valuation and Earnings This table compares Astellas Pharma

zacks.com · 19 Aug 2026

New Strong Sell Stocks for August 19th

ASEKY, ALPMY and ATS have been added to the Zacks Rank #5 (Strong Sell) List on August 19, 2026.

seekingalpha.com · 13 Aug 2026

Impax International Sustainable Economy Fund Q2 2026 Contributors And Detractors

The portfolio outperformed the MSCI EAFE benchmark in the second quarter of 2026. Contributors include Infineon Technologies, Tokyo Electron and Recruit Holdings. Detractors include Murata Manufacturing, SoftBank Group and Astellas Pharma.

zacks.com · 6 Aug 2026

New Strong Sell Stocks for August 6th

COIN, ALPMY and MUX have been added to the Zacks Rank #5 (Strong Sell) List on August 6th, 2026.

zacks.com · 22 Jun 2026

Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.